168 related articles for article (PubMed ID: 36951406)
21. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study.
Donnell D; Beesham I; Welch JD; Heffron R; Pleaner M; Kidoguchi L; Palanee-Phillips T; Ahmed K; Baron D; Bukusi EA; Louw C; Mastro TD; Smit J; Batting JR; Malahleha M; Bailey VC; Beksinska M; Rees H; Baeten JM;
Lancet HIV; 2021 Aug; 8(8):e495-e501. PubMed ID: 34126052
[TBL] [Abstract][Full Text] [Related]
22. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
[TBL] [Abstract][Full Text] [Related]
23. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
24. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
25. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
[TBL] [Abstract][Full Text] [Related]
26. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
[TBL] [Abstract][Full Text] [Related]
27. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
[TBL] [Abstract][Full Text] [Related]
28. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
[TBL] [Abstract][Full Text] [Related]
29. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
30. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
[TBL] [Abstract][Full Text] [Related]
31. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
32. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
[TBL] [Abstract][Full Text] [Related]
33. Meeting report: South African Medical Research Council Standard of Care in Clinical Research in Low- And Middle-Income Settings Summit, November 2017.
Miner MD; Bekker LG; Kredo T; Bhagwandin N; Corey L; Gray GE
Trials; 2021 Nov; 22(1):778. PubMed ID: 34742340
[TBL] [Abstract][Full Text] [Related]
34. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial.
Thomas R; Skovdal M; Galizzi MM; Schaefer R; Moorhouse L; Nyamukapa C; Maswera R; Mandizvidza P; Hallett TB; Gregson S
Trials; 2019 Dec; 20(1):668. PubMed ID: 31791405
[TBL] [Abstract][Full Text] [Related]
35. Reaching at-risk women for PrEP delivery: What can we learn from clinical trials in sub-Saharan Africa?
Stankevitz K; Schwartz K; Hoke T; Li Y; Lanham M; Mahaka I; Mullick S
PLoS One; 2019; 14(6):e0218556. PubMed ID: 31226165
[TBL] [Abstract][Full Text] [Related]
36. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
[TBL] [Abstract][Full Text] [Related]
37. HIV Pre-Exposure Prophylaxis Uptake Among High-Risk Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Nagai H; Ankomah A; Fuseini K; Adiibokah E; Semahegn A; Tagoe H
AIDS Patient Care STDS; 2024 Feb; 38(2):70-81. PubMed ID: 38381951
[TBL] [Abstract][Full Text] [Related]
38. Clinic-Level Strategies for Mitigating Structural and Interpersonal HIV Pre-Exposure Prophylaxis Stigma.
Price DM; Unger Z; Wu Y; Meyers K; Golub SA
AIDS Patient Care STDS; 2022 Mar; 36(3):115-122. PubMed ID: 35289691
[TBL] [Abstract][Full Text] [Related]
39. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
